Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04209257
Other study ID # 71011-PHI
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 2012
Est. completion date December 2016

Study information

Verified date December 2019
Source Shriners Hospitals for Children
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The overall goal of the proposed work is to develop and to assess the feasibility of using functional electrical stimulation (FES) system to improve crouch gait in individuals with cerebral palsy that may prevent the typical downward spiral of walking function decline in individuals with CP that occurs from adolescence into adulthood.


Description:

Aim 1: To assess the feasibility of using a multiple channel FES system to produce an immediate neuroprosthetic effect to reduce crouch gait in children and adolescents with spastic diplegic CP.

Aim 2: To assess the feasibility of using a multiple channel FES system as a therapeutic training tool to produce lasting neurotherapeutic effects of diminished crouch gait in children and adolescents with CP.


Recruitment information / eligibility

Status Completed
Enrollment 13
Est. completion date December 2016
Est. primary completion date December 2016
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 10 Years to 18 Years
Eligibility Inclusion Criteria:

- Age 10-18

- Spastic CP (di-, tetra-, or triplegia)

- Levels I-II GMFCS classification

- Sufficient covering of the femoral head in the acetabulum (migration % < 40)

- Mild crouch gait (minimum knee flexion 21-40o during stance)

- Potential to gain > 20 degrees knee extension improvement in stance phase

- Minimum of 0o ankle dorsiflexion passive range of motion (PROM)

- Visual, perceptual, cognitive, and communication skills to follow multiple step commands for attending to exercise and data collection

- Seizure-free or well controlled seizures

Exclusion Criteria:

- Athetoid, ataxic, or hemiplegic CP

- Significant scoliosis (primary curve > 40°)

- Spinal fusions extending into the pelvis

- Severe tactile hypersensitivity

- Joint instability or dislocation in lower extremity

- Lower extremity surgery or fractures in the past year

- Botox injections to Lower extremity in the past 6 months

- Implanted medical device contraindicated with application of FES

- Severe spasticity in Lower extremity (Mod Ashworth 4)

- Lower extremity joint pain during walking

- Hx of pulmonary disease limiting exercise tolerance or Hx of cardiac disease

- Severely limited range of motion / contractures (>15o knee flex or >15o hip flex contractures)

- Pregnancy

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Functional Electrical Stimulation.
Functional electrical stimulation - electrical stimulation applied to a muscle during an activity (i.e. ankle dorsiflexors during swing phase of gait). It assists / elicits muscle activation in order to achieve a task.

Locations

Country Name City State
United States Shriners Hospitals for Children, Philadelphia Philadelphia Pennsylvania

Sponsors (1)

Lead Sponsor Collaborator
Shriners Hospitals for Children

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in the Muscle Tone We use the Modified Ashworth Scale to measure resistance to passive movement about a joint with varying degree of velocity (Muscle tone/spasticity). Score ranges from 0-4, with 6 choices where score of 0 means no increase in tone and score of 4 means rigid limb with no flexion or extension. Our training approach using repetitive electrical stimulation may also lower spasticity, which can also facilitate improved functional mobility. Change from the baseline Modified Ashworth Scale at 14 weeks (post training)
Primary Change in the Muscle Tone We use the Modified Ashworth Scale to measure resistance to passive movement about a joint with varying degree of velocity (Muscle tone/spasticity). Score ranges from 0-4, with 6 choices where score of 0 means no increase in tone and score of 4 means rigid limb with no flexion or extension. Our training approach using repetitive electrical stimulation may also lower spasticity, which can also facilitate improved functional mobility. Change from the baseline Modified Ashworth Scale at 27 weeks (Follow up)
Primary Metabolic Cost of Walking Walking Energy Expenditure will be measured via indirect calorimetry at the subject's self-selected walking speed. The subject will walk on the treadmill while breathing into a VMax gas-dilution SensorMedics metabolic measurement system. The subject will warm up at a slow walking speed for 3 minutes, walk for approximately 5 minutes at the subject's self-selected walking speed until steady state is reached, and then sit for a 3-minute cool down. The metabolic cost of walking is computed over the 5-minute walking period. Change from the baseline Metabolic Cost of Walking at 14 weeks (post training)
Primary Metabolic Cost of Walking Walking Energy Expenditure will be measured via indirect calorimetry at the subject's self-selected walking speed. The subject will walk on the treadmill while breathing into a VMax gas-dilution SensorMedics metabolic measurement system. The subject will warm up at a slow walking speed for 3 minutes, walk for approximately 5 minutes at the subject's self-selected walking speed until steady state is reached, and then sit for a 3-minute cool down. The metabolic cost of walking is computed over the 5-minute walking period. Change from the baseline Metabolic Cost of Walking at 27 weeks (Follow up)
Primary Change in the Walking Speed Walking Speed is measured via the 10-meter walk test. This time taken to complete the task is used to compute the average walking speed referred to as "self-selected" walking speed. Change from the baseline Walking speed at 14 weeks (Post training)
Primary Change in the Walking Speed Walking Speed is measured via the 10-meter walk test. This time taken to complete the task is used to compute the average walking speed referred to as "self-selected" walking speed. Change from the baseline Walking speed at 27 weeks (Follow up)
Primary Change in the Walking Distance Walking distance (in a fixed period of time) is an indicator of endurance. Walking Distance is measured via the 6-minute walk test. Improved motor learning and gait biomechanics from the training methods would improve gait efficiency and thus, endurance. Change from the baseline Walking Distance at 14 weeks (Post training)
Primary Change in the Walking Distance Walking distance (in a fixed period of time) is an indicator of endurance. Walking Distance is measured via the 6-minute walk test. Improved motor learning and gait biomechanics from the training methods would improve gait efficiency and thus, endurance. Change from the baseline Walking Distance at 27 weeks (Follow up)
Primary Change in Gross Motor Function Measure Gross Motor Function will be assessed via sections D and E of the Gross Motor Function Measure (GMFM) test. This test is designed to evaluate changes in gross motor function over time of children with CP. Change from the baseline GMFM score at 14 weeks (Post training)
Primary Change in Gross Motor Function Measure Gross Motor Function will be assessed via sections D and E of the Gross Motor Function Measure (GMFM) test. This test is designed to evaluate changes in gross motor function over time of children with CP. Change from the baseline GMFM score at 27 weeks (Follow up)
Primary Change in the Timed Up-And-Go (TUG time) Timed Up-And-Go (TUG) is a measure designed to assess functional mobility and balance. The subjects will be seated on an adjustable bench such that the knees and angles are at 90 degrees. Subjects will be timed as they rise, walk 3 meters, turn around, return to the bench and sit down again.assessing the impact of anticipated improvements in motor control and gait biomechanics. Change from the baseline Time Up and Go time at 14 weeks (Post training)
Primary Change in the Timed Up-And-Go (TUG time) Timed Up-And-Go (TUG) is a measure designed to assess functional mobility and balance. The subjects will be seated on an adjustable bench such that the knees and angles are at 90 degrees. Subjects will be timed as they rise, walk 3 meters, turn around, return to the bench and sit down again.assessing the impact of anticipated improvements in motor control and gait biomechanics. Change from the baseline Time Up and Go time at 27 weeks (Follow up)
Primary Change in the Mini Balance Evaluation Systems Test Score Balance Evaluation Systems Test (BESTest) is a measure of balance function. The BESTest will allow for assessing the impact of anticipated improvements in motor control and gait biomechanics from training on balance. The test has a maximum score of 28 points and minimum score of zero. Score of 28 means highest level of function and 0 means lowest level of function. Change from the baseline Mini BESTest score at 14 weeks (Post training)
Primary Change in the Mini Balance Evaluation Systems Test Score Balance Evaluation Systems Test (BESTest) is a measure of balance function. The BESTest will allow for assessing the impact of anticipated improvements in motor control and gait biomechanics from training on balance. The test has a maximum score of 28 points and minimum score of zero. Score of 28 means highest level of function and 0 means lowest level of function. Change from the baseline Mini BESTest score at 27 weeks (Follow up)
Primary Change in the Electromyography Muscle activation timing measured with Electromyography during gait analysis allows for mechanistic study of anticipated improvements in motor control and gait as well as comparison to typical norms. Change from the baseline Muscle activation at 14 weeks (Post training)
Primary Change in the Electromyography Muscle activation timing measured with Electromyography during gait analysis allows for mechanistic study of anticipated improvements in motor control and gait as well as comparison to typical norms. Change from the baseline Muscle activation at 27 weeks (Follow up)
Primary Changes in the Activities-Specific Balance Scale Score The Activities-Specific Balance Scale (ABC Scale) survey allows measurement of perceived functional mobility by assessing balance confidence to perform daily activities of living without falling. 16 items are rated on a rating scale with range of 0-100. Score of 0 means no confidence and 100 means complete confidence. Average score of 16 items is the overall score. Such measures will assess the impact of anticipated improvements in motor control and gait bio-mechanics from training. Change from the baseline ABC scale score at 14 weeks (Post training)
Primary Changes in the Activities-Specific Balance Scale Score The Activities-Specific Balance Scale (ABC Scale) survey allows measurement of perceived functional mobility by assessing balance confidence to perform daily activities of living without falling. 16 items are rated on a rating scale with range of 0-100. Score of 0 means no confidence and 100 means complete confidence. Average score of 16 items is the overall score. Such measures will assess the impact of anticipated improvements in motor control and gait bio-mechanics from training. Change from the baseline ABC scale score at 27 weeks (Follow up)
Primary Changes in the Participation in Life Events survey score Participation in life events (LIFE-H) survey measures how much a person is engaging or participating with their peers and community. Weighted score ranges between 0-10 with 0 score being no accomplishment and 10 means complete accomplishment. Such measures will assess the impact of anticipated improvements in motor control and gait biomechanics from training. Change from the baseline LIFE-H scale score at 14 weeks (Post training)
Primary Changes in the Participation in Life Events survey score Participation in life events (LIFE-H) survey measures how much a person is engaging or participating with their peers and community. Weighted score ranges between 0-10 with 0 score being no accomplishment and 10 means complete accomplishment. Such measures will assess the impact of anticipated improvements in motor control and gait biomechanics from training. Change from the baseline LIFE-H scale score at 27 weeks (Follow up)
Primary Change in Piers-Harris Children's Self-Concept Scale score Self-Perception will be measured via the Piers-Harris Children's Self-Concept Scale, Second Edition (Piers-Harris 2). This test is designed to measure self-concept as reported by the individual. It measures physical and emotional well-being and self-esteem and will allow assessment of the impact of anticipated improvements in motor control and gait biomechanics from training. The tool consists of 60 items that require the respondent to respond by circling "Yes" or "No." Raw scores are converted to standardized t-scores (mean = 50, standard deviation = 10) and percentile ranks. T-Score ranges for the total scale are: <29T is very low, 30T-39T is low, 40T-44T is low average, 45T-55T average, 56T-59T- is high average, 60T-69T is high and > 70T is very high. For the six subscales T-Score ranges < 29T is very low, 30T-39T is low, 40T-44T is low average, 45T-55T is average and > 56T is above average. Change from the baseline Piers-Harris Children's Self-Concept scale score at 14 weeks (Post training)
Primary Change in Piers-Harris Children's Self-Concept Scale score Self-Perception will be measured via the Piers-Harris Children's Self-Concept Scale, Second Edition (Piers-Harris 2). This test is designed to measure self-concept as reported by the individual. It measures physical and emotional well-being and self-esteem and will allow assessment of the impact of anticipated improvements in motor control and gait biomechanics from training. The tool consists of 60 items that require the respondent to respond by circling "Yes" or "No." Raw scores are converted to standardized t-scores (mean = 50, standard deviation = 10) and percentile ranks. T-Score ranges for the total scale are: <29T is very low, 30T-39T is low, 40T-44T is low average, 45T-55T average, 56T-59T- is high average, 60T-69T is high and > 70T is very high. For the six subscales T-Score ranges < 29T is very low, 30T-39T is low, 40T-44T is low average, 45T-55T is average and > 56T is above average. Change from the baseline Piers-Harris Children's Self-Concept scale score at 27 weeks (Follow up)
Primary Change in Joint angles Hip, Knee and Ankle Joint Angles (Kinematic data) are measured using Instrumented gait analysis (Motion capture analysis system) during seven different gait phases. Change from the baseline Joint angles at 14 weeks (Post training)
Primary Change in Joint angles Hip, Knee and Ankle Joint Angles (Kinematic data) are measured using Instrumented gait analysis (Motion capture analysis system) during seven different gait phases. Change from the baseline joint angles at 27 weeks (Follow up)
See also
  Status Clinical Trial Phase
Recruiting NCT05317234 - Genetic Predisposition in Cerebral Palsy N/A
Recruiting NCT05576948 - Natural History of Cerebral Palsy Prospective Study
Completed NCT04119063 - Evaluating Wearable Robotic Assistance on Gait Early Phase 1
Completed NCT03264339 - The Small Step Program - Early Intervention for Children With High Risk of Developing Cerebral Palsy N/A
Completed NCT05551364 - Usability and Effectiveness of the ATLAS2030 Exoskeleton in Children With Cerebral Palsy N/A
Completed NCT03902886 - Independent Walking Onset of Children With Cerebral Palsy
Recruiting NCT05571033 - Operant Conditioning of the Soleus Stretch Reflex in Adults With Cerebral Palsy N/A
Not yet recruiting NCT04081675 - Compliance in Children With Cerebral Palsy Supplied With AFOs
Completed NCT02167022 - Intense Physiotherapies to Improve Function in Young Children With Cerebral Palsy N/A
Completed NCT04012125 - The Effect of Flexible Thoracolumbar Brace on Scoliosis in Cerebral Palsy N/A
Enrolling by invitation NCT05619211 - Piloting Movement-to-Music With Arm-based Sprint-Intensity Interval Training Among Children With Physical Disabilities Phase 1
Completed NCT04489498 - Comparison of Somatometric Characteristics Between Cerebral Palsy and Normal Children, Cross-sectional, Multi Center Study
Completed NCT03677193 - Biofeedback-enhanced Interactive Computer-play for Youth With Cerebral Palsy N/A
Recruiting NCT06450158 - Robot-assisted Training in Children With CP N/A
Completed NCT04093180 - Intensive Neurorehabilitation for Cerebral Palsy N/A
Completed NCT02909127 - The Pediatric Eating Assessment Tool
Not yet recruiting NCT06377982 - Human Umbilical Cord Blood Infusion in Patients With Cerebral Palsy Phase 1
Not yet recruiting NCT06007885 - Examining Capacity Building of Youth With Physical Disabilities to Pursue Participation Following the PREP Intervention. N/A
Not yet recruiting NCT03183427 - Corpus Callosum Size in Patients With Pineal Cyst N/A
Active, not recruiting NCT03078621 - Bone Marrow-Derived Stem Cell Transplantation for the Treatment of Cerebral Palsy Phase 1/Phase 2